Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
After finishing at $486.7 in the prior trading day, HCA Healthcare Inc (NYSE: HCA) closed at $485.15, down -0.32%. In other words, the price has decreased by -$0.32 from its previous closing price. On the day, 1.07 million shares were traded. HCA stock price reached its highest trading level at $490.05 during the session, while it also had its lowest trading level at $483.25.
Ratios:
Our goal is to gain a better understanding of HCA by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 101.47 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.67. For the most recent quarter (mrq), Quick Ratio is recorded 0.76 and its Current Ratio is at 0.85.
BofA Securities Downgraded its Buy to Neutral on July 16, 2025, while the target price for the stock was maintained at $394.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 05 ’25 when McAlevey Michael R sold 3,892 shares for $473.79 per share. The transaction valued at 1,843,991 led to the insider holds 3,487 shares of the business.
Michael R McAlevey bought 3,892 shares of HCA for $1,843,991 on Nov 05 ’25. On Sep 08 ’25, another insider, Cuffe Michael S., who serves as the Officer of the company, bought 3,836 shares for $418.84 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HCA now has a Market Capitalization of 113521950720 and an Enterprise Value of 159142264832. As of this moment, HCA’s Price-to-Earnings (P/E) ratio for their current fiscal year is 18.75, and their Forward P/E ratio for the next fiscal year is 16.28. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.28. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.49. Its current Enterprise Value per Revenue stands at 2.14 whereas that against EBITDA is 10.539.
Stock Price History:
The Beta on a monthly basis for HCA is 1.36, which has changed by 0.53634906 over the last 52 weeks, in comparison to a change of 0.13844287 over the same period for the S&P500. Over the past 52 weeks, HCA has reached a high of $520.00, while it has fallen to a 52-week low of $289.98. The 50-Day Moving Average of the stock is 5.62%, while the 200-Day Moving Average is calculated to be 24.78%.
Shares Statistics:
The stock has traded on average 1.36M shares per day over the past 3-months and 1490590 shares per day over the last 10 days, according to various share statistics. A total of 229.85M shares are outstanding, with a floating share count of 158.13M. Insiders hold about 30.70% of the company’s shares, while institutions hold 62.81% stake in the company. Shares short for HCA as of 1763078400 were 4536300 with a Short Ratio of 3.34, compared to 1760486400 on 3263233. Therefore, it implies a Short% of Shares Outstanding of 4536300 and a Short% of Float of 2.8900001.
Dividends & Splits
In the trailing 12 months, HCA’s forward annual dividend rate was 2.82, compared to 2.82 this year. Against a Trailing Annual Dividend Yield of 0.0057941233. The stock’s 5-year Average Dividend Yield is 0.75.
Earnings Estimates
The performance of HCA Healthcare Inc (HCA) in the stock market is under the watchful eye of 20.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is $7.19, with high estimates of $7.6 and low estimates of $6.78.
Analysts are recommending an EPS of between $27.92 and $26.56 for the fiscal current year, implying an average EPS of $27.64. EPS for the following year is $29.75, with 22.0 analysts recommending between $31.42 and $27.77.
Revenue Estimates
19 analysts predict $19.66B in revenue for. The current quarter. It ranges from a high estimate of $20.05B to a low estimate of $19.2B. As of. The current estimate, HCA Healthcare Inc’s year-ago sales were $18.29BFor the next quarter, 19 analysts are estimating revenue of $19.18B. There is a high estimate of $19.42B for the next quarter, whereas the lowest estimate is $18.61B.
A total of 22 analysts have provided revenue estimates for HCA’s current fiscal year. The highest revenue estimate was $76.14B, while the lowest revenue estimate was $74.48B, resulting in an average revenue estimate of $75.69B. In the same quarter a year ago, actual revenue was $70.6BBased on 21 analysts’ estimates, the company’s revenue will be $79.11B in the next fiscal year. The high estimate is $80.6B and the low estimate is $77B.
